Clinical Trial Update: To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of three dose levels of ciclesonide nasal spray for perennial allergic rhinitis in pediatric patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hay Fever
• Perennial Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Rhinitis, Allergic, Perennial, Hay Fever | Phase 3 | Status: COMPLETED